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The ‘capping’ of loop-C at each transmitter binding site has been proposed to
initiate the AChR channel-opening isomerization. We recorded single-channel
currents from various loop-C constructs (adult mouse; both a-subunits, 188-
198: VFYSCCPTTPY), both with and without ACh, to probe its role in binding
vs. gating. One construct (11gly) had glycines at all positions, and others had
n=9, 7, 5 or 3 glycines. The loop Amutation aA96Hwas added as a background
to increase constitutive activity. 1) None of these constructs altered the unli-
ganded gating activity. 2) The open-probability of the 11gly-construct was
not increased by 1mM ACh. 3) Reverting only two amino acids (bold) in the
11gly-construct to tyrosines generated AChRs that were activated by ACh,
again without altering unliganded gating. These results suggest that loop-C is
mainly involved in agonist binding.
A sequential kinetic scheme has been used to describe brief and long unliganded
openings in AChRs with background pore mutations (bdM2,9’-S). We com-
pared this scheme with others using AChRs activated by low [ACh], in a con-
struct that had only one functional binding site (aW149Fþbd9’SþεP121R).
The interval durations were fitted across-concentrations using three different
kinetic schemes, each having four states (C, O, AC and AO). The best fit was
obtained by using the full cycle (MWC model). The estimated increase in the
gating equilibrium constant with ACh (~740-fold) was similar to that obtained
previously by saturating the binding site (~690-fold). These results show that
a cyclic scheme describes brief/long unliganded openings at low [ACh] and
can be used to estimate the association/dissociation rate constants to the high-
affinity, open transmitter binding site.
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Fetal-type neuromuscular AChRs are composed of (a1)2bdg subunits, whereas
adult-type have the stoichiometry (a1)2bdε. g-AChRs are indispensable for
functional synapse formation, and mutations in this receptor subtype have
been associated with congenital myasthenia, multiple pterygium syndrome
and premature death. Cellular responses to transmitter molecules are influenced
by a receptor’s unliganded gating energy, G0. In mouse ε-AChRs,
G0=þ8.4 kcal/mol (100 mV). We estimated this intrinsic gating energy in
g-AChRs (single-channels, HEK cells), from measurements of the unliganded
gating equilibrium constant E0 (G0=-0.59lnE0). E0 was extrapolated from ob-
served E0 values in g-AChRs having different combinations of background
mutations that increased constitutive activity. First, 12 different background
mutations were characterized separately (by measuring the diliganded gating
equilibrium constant with choline) and were found to alter only G0 and not
the energy from the agonist. The effects of the mutations in g-AChRs were
approximately the same as in ε-AChRs. The extrapolation was based on two
assumptions, that the change in the diliganded gating equilibrium constant
(E2) is caused by only an equivalent change in G0, and that the G0 changes
are independent. A log-log plot of E0
obs vs. E2
mut/E2
wt resulted in straight
line with slope 1.0850.09, validating the two assumptions. From the extrapo-
lation, E0
wt,g = 4.8108, or G0wt,g =þ9.9 kcal/mol. This value is ~þ1.5 kcal/
mol larger than ε-AChR value. The inherent ‘slower’ kinetics of g- vs.
ε-AChRs may, in part, be attributed to the elevated intrinsic energy barrier of
the gating transition state. The results are discussed in the light of a MWC
thermodynamic cycle, to derive other equilibrium and kinetic parameters for
g-AChRs. This works lays the foundation for understanding the fetal-type
AChR transmitter binding site.
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Nicotinic acetylcholine receptors (nAChR) play important roles in various
physiological functions including pain, anxiety, fatigue, memory and learn-
ing. The a3b4 nAChR subtype has been implicated in various conditions, in-cluding lung cancer and nicotine addiction. Selective nAChR antagonists are
invaluable for evaluating the functional roles of nAChR subtypes in the ner-
vous system. a-Conotoxins that act as nAChR antagonists have been identi-
fied from the venom of predatory marine cone snails. We previously reported
the discovery of a new a4/7-conotoxin, RegIIA, isolated from Conus regius.
RegIIA inhibits acetylcholine (ACh)-evoked currents mediated by a3b2,
a3b4 and a7 nAChR subtypes. RegIIA is the most potent a3b4 nAChR
antagonist known, to date, with an IC50 of 48 nM (Franco, A., et al.
2012. Biochem. Pharmacol. 83:419-426). This study aims to understand
and improve RegIIA’s selectivity profile at the a3b4 nAChR subtype. It
uses alanine scan mutants of non-cysteine residues within loop 2 of RegIIA,
which were synthesised using solid-phase peptide synthesis. These mutants
were functionally tested on nAChRs expressed in Xenopus oocytes using
two-electrode voltage clamp recording. Of these mutants, [N11A] and
[N12A] RegIIA exhibited a three-fold increase in selectivity for a3b4, com-
pared with the a3b2 nAChR subtype. Molecular dynamics simulations of
RegIIA bound to the ACh binding pocket of the a3b4 nAChR subtype re-
vealed crucial molecular interactions, including residues of the ‘‘aromatic
cage’’ at the a3(þ) principal face (W174, Y215, Y222) as well as the
b4(-) complementary face (W79, K81, R135). This study extends our under-
standing of RegIIA interactions with various nAChR subtypes and elucidated
the key residues involved on both the peptide and the receptor binding site.
Furthermore, we have obtained valuable information about the future design
and development of a3b4-selective drugs that could target lung cancer and
nicotine addiction.
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Energetic Changes in the b Subunit during Gating of the Muscle Nicotinic
Receptor
Gustav Akk, Megan Eaton, Ping Li, Joshua Lo, Stephen Zheng,
Joe Henry Steinbach.
Washington University, Saint Louis MO, MO, USA.
The transmitter-binding sites in the adult muscle-type nicotinic receptor are
located at the interfaces between the a subunit and the d or ε subunits, while
the b subunit does not contribute to binding. The b subunit is termed a "struc-
tural" subunit as a result. We made mutations to 27 residues in the mouse
muscle b subunit (2 to 4 mutations at each location) to measure the conse-
quences on the channel opening and closing rates. We analyzed the results
in terms of the effect on the ratio of the opening to closing rates (q) and,
when sufficiently large changes occurred, on the slope of the logarithmic re-
lation between the opening rate and q (4). 4 can be interpreted in terms of the
timing during channel activation when a given residue makes an energetic
contribution to gating. We examined 12 positions in the extracellular domain
(ECD) of the b subunit, chosen because mutations to homologous residues in
other subunits had large effects on q. In contrast, mutations at the locations in
b produced small changes in gating. We examined 15 positions in the second
transmembrane (TM2) and TM2-TM3 linker regions. The majority of loca-
tions showed larger changes in q(typically > 1 kcal/mole). Estimates of 4
were consistent with the idea that the energetic contributions from residues
in the b subunit occurred later than for homologous residues in the a subunit
but before residues in d.
Overall, the data suggest that the ECD and the interface between the ECD and
TM domains of bmake little contribution to the energetics of gating. However,
channel-lining residues do contribute, although the data suggest that the timing
is later than for the a subunit. (NS22356 & NS72770)
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Effect of Membrane Hydrophobic Thickness on the Uncoupling of
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The effects of allosteric modulators on the nicotinic acetylcholine receptor
(nAChR) are usually interpreted in terms of a model involving pre-existing
resting, open, and desensitized conformations. The nAChR also adopts
a lipid-dependent non-activatable conformation, referred to as the ‘‘un-
coupled’’ state. Neither the global secondary structure nor the thermal denatur-
ation of the nAChR is greatly affected by uncoupling, although uncoupling
leads to an increase in peptide hydrogen exchange suggesting that previously
buried peptide hydrogens become exposed to aqueous solvent. We propose
that uncoupling results from a weakening of the physical interactions at the
interface between the agonist binding and transmembrane pore domains be-
cause of lipid-dependent alterations of M4/Cys-loop interactions. As a prelim-
inary test of this model, we reconstituted the nAChR into phosphatidylcholine
Wednesday, February 6, 2012 635a(PC) membranes with varying hydropho-
bic thicknesses. While the nAChR in
each PC membrane adopts an uncoupled
conformation, long acyl chain lipids
promote very slow agonist-induced con-
formational transitions to the desensi-
tized state. Hydrophobic thickness likely
influences the ability of the nAChR to
undergo agonist-induced conformational
transitions by promoting a-helix/a-helix
interactions, which appears to lower the
activation energy barriers between un-
coupled and coupled conformations.3261-Pos Board B416
Alpha7 Nicotinic Receptors: Intrinsic Kinetics and Modulation by PNU
120596
Arpad Mike, Krisztina Pesti, Anett K. Szabo, E.S. Vizi.
Inst. of Experimental Medicine, Budapest, Hungary.
We investigated the kinetics of choline evoked currents, and the effect of the
positive modulator PNU 120596 on alpha7 nicotinic acetylcholine receptors
expressed by GH4C1 cells (obtained from Siena Biotech SpA) in whole-cell
and outside-out patch-clamp experiments. using a theta-tube system for rapid
application of agonists, we measured the dependence of current kinetics on
the solution exchange rate. By extrapolation and by kinetic modeling we es-
timated the intrinsic kinetics of the receptor: what would be the amplitude
and kinetics of choline-evoked currents at instantaneous agonist application.
In the presence of PNU 120596 the single channel mean open time is dras-
tically prolonged, this allowed us to determine the ratio of simultaneously
open channels using nonstationary fluctuation analysis. By determining the
approximate number of channels in a patch, we could determine the peak
open probability of 10 mM choline-evoked currents in the absence of the
modulator (0.0333 5 0.0056), as well as the open probability in the pres-
ence of 10 mM choline and 10 mM PNU 120596 (0.632 5 0.065). We per-
formed kinetic experiments to determine the affinity of PNU 120596 to three
different conformational states of the receptor: resting state, desensitized
state and a slowly developing second desensitized state. We found that
PNU 120596 was ineffective at both the resting and the slow desensitized
states, while it bound to the desensitised state and re-activated the receptors.
We investigated the nature of cooperativity between the agonist and the
modulator. We found that while the agonist increases the apparent affinity
of the modulator only by inducing desensitized conformation (which is pre-
ferred by the modulator), the modulator induces a true increase of agonist
affinity probably by allosterically affecting the conformation of the agonist
binding site itself.
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Anesthetic Binding Sites within the Transmembrane Domain of the a7
Nicotinic Acetylcholine Receptor
Vasyl Bondarenko, David Mowrey, Yan Xu, Pei Tang.
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General anesthetics inhibit the a7 neuronal nicotinic acetylcholine receptor
(nAChR) with different sensitivities, but the location of anesthetic binding
sites remains unclear. Here we used high-resolution solution NMR to study
the interaction of general anesthetics ketamine and halothane with the trans-
membrane domain (TMD) of the human a7 nAChR. The TMD was expressed
in E. coli and purified into detergent LDAO micelles. The specific residues
involved in anesthetic binding were identified by anesthetics-induced chemi-
cal shift changes in 1H-15N HSQC NMR spectra. Ketamine binds to an intra-
subunit site involving residues of all four helices at the intracellular end of the
TMD. Two halothane interaction sites were detected. The first site was located
near the intracellular end of the TMD, similar to the ketamine site, but in-
volved only residues in TM1 and TM2. The second halothane site was formed
by residues in the middle of TM1 and TM3. This site was not observed for
ketamine binding, probably because ketamine was too large to penetrate
deep into the TMD. Interestingly, unlike the previous finding in the a4b2
nAChR, anesthetic binding to the extracellular end of the TMD was not ob-
served in the a7 nAChR. This difference may be responsible for their distinct
sensitivity to halothane. In addition, halothane modulated motion less in a7
than in a4b2 on the micro- to milli-second (ms-ms) timescale, as demonstrated
by changes in peak intensity, line width, and peak splitting for some residues.
This work was supported by NIH grants: R01GM066358, R01GM056257, and
R37GM049202.3263-Pos Board B418
Probing the Trans-Membrane Domain of GLIC, a Prokaryotic Ligand-
Gated Ion Channel
Mona A. Alqazzaz, Sarah CR Lummis.
University of Cambridge, Cambridge, United Kingdom.
The Gloeobacter ligand-gated ion channel, GLIC, has up to 28% sequence
identity with eukaryotic Cys-loop receptors, and many key residues are con-
served, especially in the 2nd trans-membrane pore lining region, M2. The
M2 region is responsible for ion selectivity, ion flux, and binding a wide range
of non-competitive inhibitors (Alqazzaz et al., 2011). The aim of this work was
to investigate the GLIC M2 region, especially His235 (or 11’), which has been
proposed as essential in proton sensing linked to channel opening (Wang et al.,
2012), and residues that are conserved across the Cys-loop receptor family. To
probe the roles of specific amino acids in GLIC M2 trans-membrane domain,
we substituted M2 residues lining the ion pore and M2 residues facing M3
trans-membrane domains. We generated over 40 mutations at various positions
including those at Glu 222(-2’), Thr 226 (2’), Ser 230 (6’), Leu 232 (8’), Ile 233
(9’), Ala 234 (10’), Ile 236 (12’), Ala 237 (13’) and Phe 238 (14’) using site-
directed mutagenesis, and tested their function using two-electrode voltage
clamp as previously described (Alqazzaz et al., 2011). Our results showed
that Ser6’, Ile9’ and His11’ residues are very sensitive to subsitution with all
substituents resulting in non-functional receptors. We conclude that His 11’
has a role in channel opening/closing, and the residues Thr226, Ser230, and
Ile233 also play an important role in receptor function.
Alqazzaz M, Thompson AJ, Price KL, Breitinger HG, Lummis SC (2011). Cys-
loop receptor channel blockers also block GLIC. Biophysical journal 101(12):
2912-2918.
Wang HL, Cheng X, Sine SM (2012). Intramembrane proton binding site
linked to activation of bacterial pentameric ion channel. The Journal of biolog-
ical chemistry 287(9): 6482-6489.
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ELIC is a prokaryotic pentameric ligand gated ion channel (pLGIC) homolo-
gous to Cys-loop receptors, which are molecular targets of general anesthetics
and alcohols. Crystal structures of ELIC and its complex with the antagonist
acetylcholine have been resolved recently, suggesting the possibility of using
ELIC to understand the structural basis of anesthetic and alcohol modulation
on pLGICs. However, the pharmacological profiles of ELIC for modulation
by general anesthetics and alcohols have not been well defined. In this study,
we characterized these profiles for ELIC expressed in Xenopus laevis oocytes
with two-electrode voltage clamp techniques. We found that the ELIC current
elicited by the agonist propylamine could be inhibited by both volatile and
intravenous general anesthetics at clinically relevant concentrations. ELIC is
also inhibited by ethanol and other n-alcohols with potency increasing with
the number of carbons until n-nonanol, where inhibition is cut off. Alcohol
modulation on ELIC is similar to that on GABAR-r1 but different from
nAChRs, which are potentiated by ethanol. In addition, ELIC is inhibited by
the benzodiazepine drug diazepam. In summary, ELIC shares some pharmaco-
logical characteristics of cation-conducting eukaryotic pLGICs and is a suitable
model for the structural study of the actions of general anesthetics and
alcohols on pLGICs. Supported by NIH (R01GM066358, R01GM056257,
and R37GM049202).
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